Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy of SPM 927 in painful diabetic neuropathy
2004-000960-28Phase 3Completed
- Sponsor
- Schwarz Pharma
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in diabetic neuropathy, sponsored by Schwarz Pharma. Primary endpoint: Adverse events. Started Sep 2004; status: completed.
02
Drugs
lacosamide
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on 2004-000960-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000960-28.